Design and Objectives of the Acorn Study: A Non-Interventional Study Evaluating Long-term Safety in Achondroplasia Patients Treated with Vosoritide

被引:0
|
作者
Pimenta, Jeanne M. [1 ]
Cohen, Shelda [1 ]
Mukherjee, Swati [1 ]
Fettes, Fiona [1 ]
Jayaram, Kala [2 ]
Lausch, Ekkehart [3 ]
机构
[1] BioMarin UK Ltd, London, England
[2] BioMarin Pharmaceut Inc, Novato, CA USA
[3] Univ Freiburg, Sect Pediat Genet, Ctr Pediat, Freiburg, Germany
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
T8
引用
收藏
页码:127 / 128
页数:2
相关论文
共 50 条
  • [11] The PANGAEA study design – a prospective, multicenter, non-interventional, long-term study on fingolimod for the treatment of multiple sclerosis in daily practice
    Tjalf Ziemssen
    Raimar Kern
    Christian Cornelissen
    BMC Neurology, 15
  • [12] LONG-TERM NON-INTERVENTIONAL STUDY OF LACOSAMIDE SAFETY AS ADD-ON THERAPY IN PATIENTS WITH EPILEPSY AND UNCONTROLLED PARTIAL-ONSET SEIZURES
    Steinhoff, B. J.
    Eckhardt, K.
    Doty, P.
    De Backer, M.
    Brunnert, M.
    Schulze-Bonhage, A.
    EPILEPSIA, 2014, 55 : 113 - 114
  • [13] Interim results (3-year) of a French non-interventional study to assess the long-term safety and efficacy of BeneFIX
    Rothschild, C.
    Trossaert, M.
    Claeyssens-Donadel, S.
    Lambert, T.
    Hassoun, A.
    Volot, F.
    Attal, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 428 - 428
  • [14] Interim results (2-year) of a French non-interventional study to assess the long-term safety and efficacy of BeneFIX
    Rothschild, C.
    Trossaert, M.
    Claeyssens, S.
    Lambert, T.
    Hassoun, A.
    Volot, F.
    Dubanchet, A.
    HAEMOPHILIA, 2012, 18 : 23 - 24
  • [15] Study Design and First Results of a Non-Interventional Registry Study To Establish Long-Term Safety and Pharmaco-Economic Data on Fingolimod (Gilenya®) in Multiple Sclerosis Patients in Germany (PANGAEA)
    Ziemssen, Tjalf
    van Lokven, Tom
    Kempke, Raimar
    Meergans, Matthias
    NEUROLOGY, 2012, 78
  • [16] Study design and first results of a non-interventional registry study to establish long-term safety and pharmaco-economic data on fingolimod (Gilenya®) in multiple sclerosis patients in Germany (PANGAEA)
    Ziemssen, T.
    van Lokven, T.
    Kempcke, R.
    Meergans, M.
    JOURNAL OF NEUROLOGY, 2012, 259 : S72 - S72
  • [17] Long-term effectiveness of fingolimod in multiple sclerosis patients treated in the routine care of Greece: results of the 'DIAMOND' non-interventional, prospective, observational study
    Mitsikostas, D. D.
    Zafeiropoulou, E.
    Iliopoulos, I.
    Fakas, N.
    Thomaides, T.
    Maltezou, M.
    Grigoriadis, N.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 900 - 900
  • [18] X-Tab: Non-interventional Long-Term Study with Omalizumab in severe Asthma in Germany
    Schreiber, Jens
    Mailaender, Claudia
    INTERNIST, 2018, 59 : S74 - S74
  • [19] Non-interventional study comparing treatment satisfaction in patients treated with antihistamines
    De Vos, Christine
    Mitchev, Krassimir
    Pinelli, Marie-Etienne
    Derde, Marie-Paule
    Boev, Rossen
    CLINICAL DRUG INVESTIGATION, 2008, 28 (04) : 221 - 230
  • [20] Non-Interventional Study Comparing Treatment Satisfaction in Patients Treated with Antihistamines
    Christine De Vos
    Krassimir Mitchev
    Marie-Etienne Pinelli
    Marie-Paule Derde
    Rossen Boev
    Clinical Drug Investigation, 2008, 28 : 221 - 230